Omnia Family Wealth LLC Sells 249 Shares of Colgate-Palmolive Company $CL

Omnia Family Wealth LLC trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,566 shares of the company’s stock after selling 249 shares during the quarter. Omnia Family Wealth LLC’s holdings in Colgate-Palmolive were worth $506,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Cornerstone Wealth Management LLC lifted its position in shares of Colgate-Palmolive by 1.2% during the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock valued at $847,000 after buying an additional 110 shares in the last quarter. Grimes & Company Inc. lifted its position in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock valued at $1,136,000 after buying an additional 118 shares in the last quarter. RFG Advisory LLC lifted its position in shares of Colgate-Palmolive by 1.4% during the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after buying an additional 123 shares in the last quarter. Redhawk Wealth Advisors Inc. lifted its position in shares of Colgate-Palmolive by 2.4% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after buying an additional 129 shares in the last quarter. Finally, MONECO Advisors LLC lifted its position in shares of Colgate-Palmolive by 2.2% during the 1st quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock valued at $567,000 after buying an additional 133 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CL. UBS Group decreased their target price on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Morgan Stanley decreased their target price on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. Citigroup reduced their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research note on Monday, August 4th. Finally, Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $92.21.

Colgate-Palmolive Stock Down 0.9%

Shares of CL opened at $77.67 on Thursday. Colgate-Palmolive Company has a 52-week low of $76.68 and a 52-week high of $101.89. The company has a market capitalization of $62.77 billion, a PE ratio of 21.82, a price-to-earnings-growth ratio of 4.60 and a beta of 0.34. The stock has a fifty day simple moving average of $82.20 and a two-hundred day simple moving average of $87.60. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the company earned $0.91 EPS. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.